Clinical trial

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

NCT06523673

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-09-01

PhasePHASE3

Study timeline

Study start (estimated)2024-09-01Date precision: month

Registry last updated2024-08-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Non-Small Cell Lung Cancerunresolved

NSCLC Stage IVunresolved

OligoProgressive Metastatic Diseaseunresolved

Interventions

Stereotactic Body RadiotherapyRADIATION

second-line systemic therapyDRUG

Sponsors & collaborators

Second Affiliated Hospital, Zhejiang University, School of Medicinelead sponsor

Mapped research locations

HangzhouZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06523673 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.